Your browser doesn't support javascript.
loading
Combination therapy of ustekinumab and immunomodulator for inflammatory bowel disease: concerns about the different results observed between two meta-analyses.
Yoshihara, T; Shinzaki, S; Iijima, H; Tsujii, Y; Hayashi, Y; Takehara, T.
Afiliação
  • Yoshihara T; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Shinzaki S; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Iijima H; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo Medical University, Nishinomiya, Japan.
  • Tsujii Y; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Hayashi Y; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Takehara T; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.
J Gastroenterol Hepatol ; 38(5): 830-832, 2023 05.
Article em En | MEDLINE | ID: mdl-36866596
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Ustekinumab Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Ustekinumab Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article